Goto

Collaborating Authors

100 artificial intelligence companies to know in healthcare 2019: Artificial intelligence and machine learning are quickly becoming an integral part of healthcare delivery.

#artificialintelligence

Artificial intelligence and machine learning are quickly becoming an integral part of healthcare delivery. Both on the clinical care and operational side of healthcare organizations, AI has is powering technology that keeps patients safe and improves efficiency for the revenue cycle, supply chain and more. Here are 100-plus companies in the healthcare space using artificial intelligence. To add a company to this list, contact Laura Dyrda at ldyrda@beckershealthcare.com. AiCure is an AI and advanced data analytics company that uses video, audio and behavioral data to better understand the connection between patients, disease and treatment. It allows physicians to have access to clinical and patient insights.


AI in Precision Medicine in 2018

#artificialintelligence

The Precision Medicine World Conference will be one of the most exciting conferences focused on AI in healthcare in 2018. CEOs of cutting edge companies from around the world will come together to discuss how they are using techniques such as computer vision, deep learning and machine learning to make big advances in medicine from drug discovery to patient diagnosis and treatment. The program will traverse innovative technologies and clinical case studies that enable the translation of precision medicine into direct improvements in health care. Attendees will have an opportunity to learn about the latest developments in Precision Medicine and cutting-edge new strategies that are changing how patients are treated.


Defining the Opportunity: Machine Learning in Radiology - Signify Research

#artificialintelligence

Computer-aided detection (CADe) systems are intended to identify a variety of cancers such as breast cancer, prostate cancer, and lung lesions. They are most commonly used to detect microcalcifications and masses on screening mammograms. Despite concerns regarding the benefits of CADe and the high rate of false positives and false negatives, the market has grown steadily over the last two decades, most notably in the US where more than 90% of mammograms are interpreted using CADe. This has largely been driven by the availability of reimbursement for the use of CADe in breast screening. It is far less commonly used for detecting other cancers, where reimbursement for using CADe is currently not available.


Startups Disrupting Healthcare with AI and Machine Learning

#artificialintelligence

Increasingly crowded imaging & diagnostics: 17 out of the 22 companies under imagining & diagnostics raised their first equity funding round since January 2015 (this includes 1st Seed or Series A rounds, as well as a first round raised by stealth startup Imagen Technologies). In 2014, Butterfly Networks raised a $100M Series C, backed by Aeris Capital and Stanford University. This was the third-largest equity round to AI in healthcare companies, after China-based iCarbonX's $154M mega-round and two $100M raises by oncology-focused Flatiron Health. VCs invest in drug discovery: Startups are using machine learning algorithms to reduce drug discovery times, and VCs have backed 6 out of the 8 startups on the map. Andreessen Horowitz recently seed-funded twoXAR, developer of the DUMA drug discovery platform; Khosla Ventures and Data Collective backed Atomwise, which published its first findings of Ebola treatment drugs last year, and has also partnered with MERCK; Lightspeed Venture Partners invested in Numedii in 2013; Foundation Capital participated in 3 equity funding rounds to Numerate.


From Virtual Nurses To Drug Discovery: 90 Artificial Intelligence Startups In Healthcare

#artificialintelligence

Increasingly crowded imaging & diagnostics: 17 out of the 22 companies under imagining & diagnostics raised their first equity funding round since January 2015 (this includes 1st Seed or Series A rounds, as well as a first round raised by stealth startup Imagen Technologies). In 2014, Butterfly Networks raised a $100M Series C, backed by Aeris Capital and Stanford University. This was the third-largest equity round to AI in healthcare companies, after China-based iCarbonX's $154M mega-round and two $100M raises by oncology-focused Flatiron Health. VCs invest in drug discovery: Startups are using machine learning algorithms to reduce drug discovery times, and VCs have backed 6 out of the 9 startups on the map. Andreessen Horowitz recently seed-funded twoXAR, developer of the DUMA drug discovery platform; Khosla Ventures and Data Collective backed Atomwise, which published its first findings of Ebola treatment drugs last year, and has also partnered with MERCK; Lightspeed Venture Partners invested in Numedii in 2013; Foundation Capital participated in 3 equity funding rounds to Numerate.